Vasodilator treatment with hydralazine increases blood flow in mdx mice resistance arteries without vascular wall remodelling or endothelium function improvement.

Loufrani, Laurent

Vasodilator treatment with hydralazine increases blood flow in mdx mice resistance arteries without vascular wall remodelling or endothelium function improvement. [electronic resource] - Journal of hypertension Oct 2005 - 1855-60 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

0263-6352

10.1097/01.hjh.0000183944.25832.81 doi


Acetylcholine--pharmacology
Animals
Blood Flow Velocity--drug effects
Blood Pressure
Body Weight
Calcium--pharmacology
Dystrophin--genetics
Endothelium, Vascular--physiology
Enzyme Inhibitors--pharmacology
Hydralazine--administration & dosage
In Vitro Techniques
Male
Mesenteric Arteries--drug effects
Mice
Mice, Inbred C57BL
Mice, Inbred mdx
Mutation
NG-Nitroarginine Methyl Ester--pharmacology
Nitric Oxide Synthase--antagonists & inhibitors
Nitroprusside--pharmacology
Phenylephrine--pharmacology
Serotonin--pharmacology
Stress, Mechanical
Vascular Resistance
Vasoconstriction--drug effects
Vasoconstrictor Agents--pharmacology
Vasodilation--drug effects
Vasodilator Agents--administration & dosage